Concerns About Pinnacle Integration Ding Conagra
We plan to trim our fair value estimate as we temper our near-term sales and profitability forecast for Pinnacle.
While narrow-moat Conagra's (CAG) legacy business continues to track in line with our expectations (roughly flat organic sales and high-20s gross margin year to date), these results were largely overshadowed by concerns about the underlying health of Pinnacle (acquisition closed at end of October), which posted 11% operating margin, versus a midteens average over the last few years, on $259 million of sales (11% of revenue this quarter). Both sales and profitability fell short of Conagra's expectations, leading management to revise its 2018 estimates below Pinnacle's internal targets. We attribute this to lackluster innovation that failed to respond to evolving consumer tastes, leading to share and shelf space losses and, consequently, heightened promotional activity. In our view, the inability of these brands to command pricing power and speed at which they lost distribution supports our contention that Pinnacle lacked the brand assets or entrenched retail relationships needed to form an edge on a standalone basis.
Conagra's outlook now calls for Pinnacle to be dilutive by 40 basis points to consolidated fiscal 2019 gross margin, with Pinnacle's adjusted gross margin expected to hover around 27%, below the 29% in its last fiscal year and our above 30% estimate. We plan to trim our $37.50 by a high single-digit percentage as we temper our near-term sales and profitability forecast for Pinnacle, although we aren't anticipating any material changes to our outlook for Conagra's legacy business. Over the long run, we still view low-single-digit sales growth and midteens average operating margin (on a consolidated basis) to be feasible, as management strengthens innovation and execution within Pinnacle's brand set, though we wouldn't be surprised to see further erosion over the next few quarters as these efforts may take time to yield improvement. Shares pulled back by a high-teens percentage on the announcement and look undervalued even relative to our expected revisions.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Sonia Vora does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.